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Topoisomerase III beta (TOP3B) is one of the least understood members of the
topoisomerase family of proteins and remains enigmatic. Our recent data shed
light on the function and relevance of TOP3B to disease. A homozygous del-
etion for the TOP3B gene was identified in a patient with bilateral renal
cancer. Analyses in both patient and modelled human cells show the disrup-
tion of TOP3B causes genome instability with a rise in DNA damage and
chromosome bridging (mis-segregation). The primary molecular defect
underlying this pathology is a significant increase in R-loop formation. Our
data show that TOP3B is necessary to prevent the accumulation of excessive
R-loops and identify TOP3B as a putative cancer gene, and support recent
data showing that R-loops are involved in cancer aetiology.1. Introduction
Topoisomerase III beta (TOP3B) is a member of the IA subfamily of topoisome-
rases, which unwind negatively supercoiled DNA by cutting a single strand of
DNA and passing it through a second single DNA strand [1]. Two TOP3
enzymes exist in higher eukaryotes that have diverged from a single ancestor
present in unicellular organisms [2]. TOP3A and TOP3B both unwind nega-
tively supercoiled DNA, but their molecular and in vivo functions differ [3].
TOP3A is essential in all species and associates with BLM, RMI1 and RMI2
to form the BTRR complex, which dissolves Holliday junctions that arise
during homologous recombination [4]. Unlike TOP3A [5], Top3b null mice are
viable but present with tissue lesions and a reduced lifespan [6], as well as
chromosome instability in spermatocytes and infertility, which becomes more
pronounced after successive homozygous breeding [7].
TOP3A and TOP3B have developed distinct specificities for DNA loop
(D-loop) and RNA loop (R-loop) structures [8], respectively. In humans,
TOP3B possesses dual activities for processing topological problems for both
DNA and RNA, whereas TOP3A is DNA specific [9]. D-loops and R-loops are
bubble-like structures where one of the strands of DNA (or RNA) is displaced
by a homologous strand of DNA (D-loop) or RNA (R-loop) [10,11]. D-loops com-
monly appear during gene transcription and downstream processing of RNA,
DNA repair, DNA replication and meiotic recombination [12]. R-loops are
DNA–RNA hybrids that form when nascent RNA hybridizes with the DNA
template, leaving the non-template DNA single stranded [13,14]. R-loop for-
mation is highly dependent upon three factors: DNA nicks, high G density
and negative supercoiling [15,16]. They most commonly occur when a newly
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Figure 1. Homozygous deletion spanning the TOP3B region. (a) Patient genomic DNAwas hybridized onto an Infinium Omni2.5 (Illumina) microarray chip for high-resolution
copy number analysis. SNP genotyping and copy number levels revealed a homozygous deletion spanning a maximum of 275 kb at chr22: 22 305 007–22 579 821 (human
genome build GRCM37/hg19). Note the lack of SNP heterozygosity across the deleted region, shown by blue dots in the B-allele frequency plot. (b) (i) Immunoblots of
TOP3B and loading control α-tubulin in control (C), parental heterozygote controls (F = father, M = mother) and homozygous TOP3B-deleted patient (P) lymphoblasts.
(ii) Immunoblots of TOP3B and α-tubulin in three modelled HCT116 TOP3B null clones (1.12, 4.8 and 4.9), with parental HCT116 (HCT) as a control.
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2transcribed G-rich RNA anneals back to the C-rich template
DNA strand, largely displacing the other DNA strand [17].
It would seem that R-loops would be deleterious to the
cell. However, recent data show that R-loops at the 50 end
of genes can protect against DNA methylation, help initiate
class switch recombination at the immunoglobulin H (IgH)
locus by causing double-stranded breaks in DNA and aid
transcription termination at the 30 end of genes [17–19].
Despite the positive role R-loops play in the cell cycle, exces-
sive R-loop formation can lead to genome instability [16,20].
Several studies implicate TOP3B in processing R-loops.
TOP3B binds in a complex with TDRD3, and Tdrd3 null mice
accumulate R-loops at the C-MYC locus [21]. In vitro assays
in fly and human show that TOP3B activity can relax negatively
supercoiled DNA [8,21], an activity that prevents the formation
of R-loops.
TOP3B also appears to play an important role in neural
cell biology. A study of an isolated northern Finnish familyfound that the TOP3B gene was associated with schizophrenia
and cognitive impairment [22]. A TOP3B-associated complex
has been identified consisting of TOP3B–TDRD3–FMRP
(fragile X mental retardation protein) and has been linked to
the processing and regulation of neuronal expressed genes
[21–23]. The FMRP binds polyribosomal RNA and inhibits
the translation of neuronal mRNAs. The TOP3B–TDRD3–
FMRP complex prevents the accumulation of transcribed
RNAs in cytoplasmic compartments when the cell is stressed
[23]. Recent data have further reinforced the pivotal role
TOP3B plays in RNA biology. Drosophila S2 cells display
defective heterochromatin formation and transcriptional silen-
cing when TOP3B is disrupted, which is reminiscent of
mutants in the RNAi-induced silencing complex (RISC) [24].
While new data are emerging for TOP3B, there are still
anomalies regarding the protein and its exact functions
remain unclear. Here, we present only the second example
of a patient without the TOP3B gene. Our new data, using
Table 1. TOP3B homozygous deletion frequency was examined in the
Catalogue Of Somatic Mutations In Cancer (GRCh38 COSMIC v89, cancer.sanger.
ac.uk/cosmic).
tissues
no. of
samples
homozygous
deletion
% of
samples
adrenal gland 268 2 0.746268657
breast 1544 1 0.064766839
central nervous
system
1093 1 0.091491308
endometrium 598 1 0.16722408
haematopoietic
and lymphoid
836 0 0
kidney 1027 1 0.097370983
large intestine 773 1 0.129366106
liver 692 1 0.144508671
lung 1185 2 0.168776371
oesophagus 546 1 0.183150183
ovary 729 3 0.411522634
pleura 108 2 1.851851852
skin 650 2 0.307692308
soft tissue 268 0 0
testis 152 1 0.657894737
upper aerodigestive
tract
563 0 0
total 11 032 19 0.172226251
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3lymphoblasts from a bilateral renal cancer patient deleted
for TOP3B, show multiple hallmarks of genome instability
that were pheno-copied in modelled TOP3B null cells of a
different lineage. We show TOP3B loss results in excessive
R-loop formation, DNA damage and chromosomal instabil-
ity, and predisposes cells to cancer. Our data also support
the growing connection between R-loops and cancer [11,16].2. Results
2.1. Identification of a patient with a homozygous
deletion of TOP3B
An adult male patient was referred to Adult Cancer Genetics,
Austin Hospital, Melbourne with bilateral clear cell renal
cancer, diagnosed at the ages of 49 and 52 years. The patient
had normal growth, and abdominal and chest CT imaging
revealed no cystic lesions of liver or pancreas or lungs. On
examination, he was normocephalic with a head circumfer-
ence of 56.6 cm, and he was not syndromic in appearance.
The patient displayed sun-damaged skin with hypopigmen-
ted macules and had a number of small (less than 5 mm)
hypopigmented pitted scars on his upper chest/back. The
proband and his parents did not have schizophrenia or cog-
nitive impairment. He did not have a family history of
renal cancer, and his family history was not suggestive of a
known renal cancer-predisposing syndrome. However, bilat-
eral renal cancer is rare for a person of 50 years of age, sofurther genetic testing was suggested [25]. Indeed, studies
in Iceland found that over 60% of patients with renal cancer
had a genetic predisposition [26]. The patient had normal
VHL gene sequencing via the 94 gene Illumina TruSight
Cancer Kit on the Illumina MiSeq system, normal sanger
sequencing of the VHL promoter region, normal VHL
MLPA (salsa kit P016-C2) testing and normal bioinformatic
analysis of other genes known to cause an inherited suscep-
tibility to renal cancer using Illumina TruSight data.
Additional testing included normal tumour tissue SDHA/
SDHB immunohistochemistry and a normal g-banded karyo-
type to exclude a translocation involving chromosome 3.
SNP-microarray analysis was performed using the high-
density Illumina Human Omni2.5 chip. A homozygous
deletion was found on 22q11.22 chr22: 22 305 007–22 579 821
(human genome build GRCM37/hg19) that spanned the
TOP3B gene (figure 1a). The deletion was approximately
275 kb and was driven by 4 kb segmental duplicated regions
(99.5% homology) juxtaposed on either side of the deletion
(figure 1a). Both parents were heterozygote for the deletion.
A non-coding RNA with no known function is the only
other transcript detected in the deleted area.
To determine the frequency of the TOP3B deletion between
the two 4 kb segmental duplicated regions, we searched the
region in the gnomAD human structural variant dataset
derived from 10 738 genomes from unrelated individuals
(gnomad.broadinstitute.org). The allele frequency is 9/21
470 (0.042%), with no homozygous deletions being detected.
Interestingly, the allele frequency for duplications is higher at
0.27%, with one homozygous event being identified.
To determine whether homozygous deletions around
the TOP3B gene are enriched in cancer mutation datasets,
we examined the frequency in the Catalogue Of Somatic
Mutations In Cancer (GRCh38 COSMIC v89, cancer.sanger.
ac.uk/cosmic). We identified 19 with homozygous deletions
from 11 032 samples (0.17%) (table 1). TOP3B deletions were
found in a broad range of cancer tissue types (table 2). This
deletion frequency was markedly elevated compared with
the gnomAD dataset frequency of 0.042% for heterozygotes.
The increase may reflect the inherent genome instability in
cancer genomes, or it is possible that this homozygous variant
is a driver in cancer progression. More work needs to be done
to investigate this finding.
Two recent case reports, involving similar TOP3B genomic
deletions associated with neurological disorders, have been
reported [27,28]. Close inspection of the microarray results
shows that these structural variants are heterozygous deletions
and hence the significance of a single-copy loss remains less
significant given the approximate allele frequency of 1/2000
in the general population and up to 1/750 within certain
sub-populations. TOP3B genomic deletions are enriched in
northeastern sub-isolates compared with the rest of Finland
[22]; however, outside of the Finnish population, deletions
involving TOP3B appear to be seen with approximately
equal frequency between cases and controls [29,30].
Immunoblotting with an antibody against TOP3B showed
no detectable protein for the homozygous patient (P). Inter-
estingly, heterozygote parents (F and M) displayed a
detectable loss of TOP3B protein compared with lymphoblast
control cells (C) (figure 1b(i); electronic supplementary
material, figure S1a). To our knowledge, this represents
only the second reported case of a homozygous deletion for
TOP3B and the first where cell lines have been available for
Table 2. TOP3B homozygous deletions were found in a broad range of cancer tissue types.
sample name tissue chr start end size
TCGA-OR-A5J2-01 adrenal gland 22 21 960 940 22 199 941 239 001
TCGA-OR-A5JD-01 adrenal gland 22 21 960 940 22 219 595 258 655
TCGA-A2-A0SW-01 breast 22 21 953 147 22 326 572 373 425
TCGA-DB-A64 L-01 central nervous system 22 21 936 109 22 219 595 283 486
TCGA-A5-A0G1-01 endometrium 22 21 960 734 22 225 090 264 356
TCGA-EU-5905-01 kidney 22 21 953 147 22 225 090 271 943
TCGA-AG-A02G-01 large intestine 22 21 776 250 23 147 792 1 371 542
TCGA-G3-A25 W-01 liver 22 21 936 109 22 219 595 283 486
TCGA-56-8622-01 lung 22 21 960 717 22 225 429 264 712
TCGA-63-6202-01 lung 22 21 960 734 22 225 408 264 674
OACM5-1 oesophagus 22 21 833 371 23 806 086 1 972 715
TCGA-25-1628-01 ovary 22 21 785 127 22 354 061 5 68 934
TCGA-61-2018-01 ovary 22 21 926 720 22 187 441 260 721
TCGA-61-2109-01 ovary 22 21 819 244 21 967 362 148 118
IST-MES1 pleura 22 21 790 812 22 249 007 458 195
TCGA-ZN-A9VQ-01 pleura 22 21 960 940 22 200 684 239 744
TCGA-GN-A269-01 skin 22 21 960 940 22 225 090 264 150
VMRC-MELG skin 22 21 917 856 23 097 569 1 179 713
TCGA-2G-AAKL-01 testis 22 21 953 147 22 225 408 272 261
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4analyses (we are the second laboratory to report a TOP3B
null patient [22]). Sister-chromatid exchange levels were not
elevated when compared with parental controls (electronic
supplementary material, figure S1b left). It is of note that
the patient had no history of mental illness. This is in contrast
with other studies that have linked the TOP3B gene to autism
and schizophrenia [22,23] and juvenile myoclonic epilepsy
[28]. A semen sample was taken from the TOP3B null
patient and showed a significant reduction in total sperm
(400 000 sperm ml−1 compared with the normal concen-
tration greater than 15 000 000 sperm ml−1) and motility 0%
(normal > 50%). The fertility analysis is consistent with a
TOP3B null mouse study, which showed a high incidence
of aneuploidy in mouse spermatocytes [7].2.2. Loss of TOP3B increases DNA damage and genomic
instability
The TOP3B null patient showed no mental illness, but instead
presented with bilateral clear cell renal cancer and multifocal
and nodular lesions. Genome instability can lead to cancer
progression. A common marker of genome instability is
heightened levels of micronuclei that usually arise as a
result of chromosome loss or fragmented chromosomes not
being incorporated into the daughter nuclei. We determined
if the loss of TOP3B increased the incidence of micronuclei
compared with parental controls (figure 2). Patient lympho-
blast null cells, parental heterozygote lymphoblast control
cells, CRISPR–Cas9 engineered HCT116 TOP3B null cells
and the HCT116 isogenic control cell line were used.
HCT116 TOP3B null clones were created independently(using different guide RNAs) and one null from each guide
RNA was used for all subsequent cell biology analyses.
HCT116 TOP3B null clones (Top3B_1.12 and Top3B_4.8)
were sequenced across the TOP3B Cas9 cut site and no
TOP3B protein was detected by immunoblot (figure 1b(ii)).
Patient lymphoblast cells significantly increased micronu-
clei formation compared with parental controls (3.74% in P,
2.03% in M, 1.64% in F and 0.72% in C; figure 2a). HCT116
TOP3B null cells showed increased micronuclei formation
(figure 2a). Overall, the data show that loss of TOP3B
causes a mild increase in micronuclei formation, which is
suggestive of genome instability. Consistently, null cells
from both patient lymphoblast and HCT116 TOP3B−/− cells
showed a significant rise in DNA damage, as assessed by
immunofluorescence staining in figure 2b, using an antibody
to γ-H2AX (phosphor S139) that binds specifically at sites of
double-stranded DNA breaks [31]. γ-H2AX foci were
increased two- to threefold in patient lymphoblast cells and
two independent null HCT116 cells compared with controls
(figure 2b). Terradas et al. [32] reported that a high fraction
of cells with micronuclei displaying discrete γ-H2AX foci
were observed at an early stage post-irradiation. We found
a very large rise in the number of cells with micronuclei dis-
playing discrete γ-H2AX foci in HCT116 null cells (electronic
supplementary material, figure S1a).
Genome instability can arise as a result of defective
chromosome segregation. We therefore tested whether null
cells showed chromosome bridging defects (figure 3). Bulky
DNA bridges are readily visible with conventional DAPI
staining while ultrafine DNA bridges (UFBs) are not visible
with DNA dyes but can be detected using Plk1-interacting
checkpoint helicase (PICH) as a marker [33]. Normal cells
02.5
5.0
7.5
%
 c
el
ls 
w
ith
 m
ic
ro
nu
cl
ei
n.s.
HCT Top3B_1.12 Top3B_4.8
*
*
0
2
4
6
%
 c
el
ls 
w
ith
 m
ic
ro
nu
cl
ei
F M PC
*
*
*
n.s.
DNA g–H2AX merge
F
M
P
C
F M PC
0
20
40
10
30
%
 c
el
ls 
w
ith
 g
-
H
2A
X
 fo
ci
*
*
*
n.s.
HCT Top3B_1.12 Top3B_4.8
%
 c
el
ls 
w
ith
 >
1g
-
H
2A
X
 fo
ci
0
20
40
10
30
*
*
n.s.
g–H2AX merge
H
CT
To
p3
B_
4.
8
To
p3
B_
1.
12
DNA
(a) (i) (ii)
(i) (ii)
(i) (ii)
(b)
(c)
Figure 2. Loss of TOP3B results in increased DNA damage. (a) Micronuclei levels were determined in (i) control (C), parental heterozygote controls (F = father, M =
mother) and homozygous TOP3B-deleted patient (P) lymphoblasts and (ii) wild-type HCT116 (HCT) and TOP3B null clones (Top3B_1.12 and Top3B_4.8). Patient TOP3B
null and HCT116 null clones show an increase in micronuclei relative to controls. Inserts are representative images of cells with micronuclei. Data were collected from
three independent experiments, with at least 1000 cells scored for each experiment. (b) Representative images for (i) lymphoblasts and (ii) HCT116 cells stained for
γ-H2AX. (c) (i) Patient lymphoblasts and (ii) HCT116 TOP3B null clones show a significant increase in γ-H2AX signal. Data were collected from three independent
experiments, with at least 150 cells scored at each experiment. Asterisk denotes p < 0.05. n.s., no significant difference. Scale bar, 5 µm.
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5display a significant amount of UFBs during early anaphase,
but these are generally resolved by the BTRR complex and
the percentage of cells with UFBs drops markedly in ana-
phase B [33,34]. Increases in UFBs are often a result of
unresolved replication intermediates that persist into mitosis,while bulky bridges are more commonly formed with pro-
blems arising such as under-condensed or entangled
mitotic chromosomes during mitosis [34,35]. Our data show
a significant rise in anaphase B UFBs in both null patient lym-
phoblast and HCT116 TOP3B null cells relative to controls
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6(figure 3). Bulky bridges were increased in TOP3B null
patient versus control cells (figure 3a(iii)), but a statistically
significant increase in bulky bridges between null cells and
controls in modelled HCT116 cell lines was observed only
in one clone (figure 3b(iii)).
2.3. Loss of TOP3B results in increased R-loops
TOP3B alone has affinity for R-loops and it is also part of the
TDRD3 complex, which is involved in processing R-loops.
Therefore, we hypothesized that the genome instability we
observed was a result of increased R-loop formation. To test
this, we used a monoclonal antibody (S9.6) that specifically
recognizes RNA : DNA hybrids in a sequence-independent
manner [36,37] and analysed patient and HCT116 TOP3B
null cells with their respective controls (figure 4). The S9.6
antibody shows especially strong signals at nucleoli, which
contain R-loop-prone ribosomal arrays [38]. Treating cells
with RNaseH removed the signal, validating the specificity
of the S9.6 for the RNA structures (figure 4a(i),b(i)). The inten-
sity ratio of the S9.6 signal in the nuclei to the DAPI signal,in both patient lymphoblast null cells and independen-
tly targeted HCT116 TOP3B null cells, was significantly
higher than their respective controls. The results show that
loss of TOP3B causes accumulation of R-loops that probably
triggers the observed genomic instability, a consequence that
predisposes cells to malignancy [39].
An interesting feature of patient analyses is that the het-
erozygote parents in certain assays showed an intermediate
phenotype between control and null lymphoblasts. This
was evident in our micronuclei and R-loop analyses
(figures 2a and 4a). Immunoblotting showed there was a sig-
nificant reduction of TOP3B protein in parent cells compared
with wild-type control cells (figure 1b; electronic supplemen-
tary material, figure S1b), suggesting there could be a level of
haploinsufficiency in the heterozygote cells.
2.4. TOP3B and the DNA damage response
Replication intermediates arising from incomplete or
stalled replication are dealt with by various cellular pathways
including non-homologous end joining (NHEJ) [40]. R-loops
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8impair replication fork progression and induce replication
stress [41]. Flow cytometry profiles showed that TOP3B null
cells were not arrested in any particular cell cycle stage (elec-
tronic supplementary material, figure S1c). We tested
whether TOP3B removal interferes with DNA damage path-
ways. The p53-binding protein 1 (53BP1) is a key component
of the double-strand break signalling and repair pathway in
mammals and promotes the pathway for NHEJ-mediated
repair of double-stranded breaks (DSBs) [42]. An antibody
recognizing 53BP1 was used to stain both HCT116 and
HCT116 TOP3B null cells (figure 5a). Interestingly, null cells
showed lower levels of 53BP1 than controls, suggesting this
pathway is less active with repairing intrinsic replication
stress. We then determined whether the repair itself was
affected by analysing RAD51, a recombinase that plays a cen-
tral role in the repair of DSBs via homologous recombination
[43,44]. The level of RAD51 in null cells is heightened, con-
sistent with the increase in DNA damage (figure 5b).
BRCA1 is another protein involved in the repair of DSBs,
but no difference was observed in BRCA1 intensity between
null cells and control cells (figure 5c). BRCA1 counteracts
53BP1 by promoting DSB repair using homologous recombi-
nation instead of NHEJ [45,46]. Taken together, these results
show that elements of the DSB repair signalling pathway
are altered when TOP3B is perturbed, and suggest the
DNA damage response, as a result of intrinsic replication
stress, is diminished when TOP3B is deleted. Also, the hom-
ologous recombination pathway may be favoured over NHEJ
to repair damaged DNA.
The 53BP1 signalling response in HCT116 TOP3B null
cells appears to be lowered. We exposed cells to genotoxic
stress and examined the checkpoint responses to further
explore this result. HCT116 control and HCT116 TOP3B
null cells were treated with replication inhibitors (i.e. thymi-
dine or hydroxyurea) and the damage response was
assessed with both γ-H2AX and phospho-P53 (figure 6a,b).
Flow cytometry profiles showed that both control and null
cells were arrested in G1/S with either thymidine or hydro-
xyurea treatment (electronic supplementary material, figure
S2a). Consistent with earlier experiments, untreated HCT116
TOP3B null cells showed a greater increase in γ-H2AX
than controls. However, the situation was reversed with
HCT116 TOP3B null cells having a weaker response to
DNA damage than controls when treated with thymidine
or hydroxyurea (figure 6b(i)). At first glance this seems con-
tradictory, but the response is stronger in wild-type cells
than TOP3B null cells when treated with genotoxic agents,
suggesting some compromise in the signal response. The
higher level of DNA damage in untreated HCT116 TOP3B
null cells reflects the fact that under normal circumstances,
TOP3B-depleted cells accumulate more DNA damage.
Phospho-P53 (Ser15) was used to examine downstream sig-
nalling of γ-H2AX. Phospho-P53 at Ser15 is used to amplify
the checkpoint response signal. In untreated cells, levels of
phospho-P53 were lower in TOP3B null clones than control
cells (figure 6b(ii)). This difference was more pronounced in
TOP3B null cells than parental control when treated with
thymidine or hydroxyurea. Together, these results show
that the removal of TOP3B has a deleterious effect on the
DNA damage signalling mechanism.
Despite having a perturbed checkpoint response, HCT116
TOP3B null cells still arrest when exposed to genotoxic stress
(electronic supplementary material, figure S2a). To assess forrecovery after genotoxic stress, cells were treated with thymi-
dine, hydroxyurea or aphidicolin for 24 h, washed and
allowed to recover for 7 days. Cells on plates were stained
using crystal violet and the number of colony-forming
clones was assessed. HCT116 control and HCT116
TOP3B−/− untreated cells showed little difference in colony
forming after initially being seeded at equivalent amounts,
indicating that the growth rate is not impaired as a result of
TOP3B deficiency (figure 7a). This is consistent with our
own TOP3B null patient who was of normal height and
stature and also mice data that showed nulls develop
normally to maturity [6]. However, HCT116 TOP3B null cells
formed significantly less clones than controls after being trea-
ted with thymidine, hydroxyurea or aphidicolin and allowed
to recover for 7 days (figure 7a). This further suggests that
the repair mechanism is compromised in TOP3B-deficient
cells. We assessed cells for micronuclei formation using the
same treatment conditions. Consistent with earlier analyses
(figure 2a), there was a slight increase in the amount of
micronuclei in untreated HCT116 TOP3B null cells (TOP3B
nulls cells versus control: 4.4–7.5% versus 3.5%). However,
HCT116 TOP3B null cells treated with thymidine, hydroxyurea
or aphidicolin showed amuch greater percentage increase (thy-
midine: 19–24%; hydroxyurea: 17–26%; aphidicolin: 24–27%) in
micronuclei relative to controls (thymidine: 10%; hydroxyurea:
11%; aphidicolin: 16%; figure 7b). Consistently, a very large
increase in nuclei displaying DNA damage, as assessed by the
appearance of γ-H2AX foci, was observed when HCT116
TOP3B null cells were allowed to recover (figure 7c). A large
portion of cells retained three to four γ-H2AX foci when
recovered from replication stress. Furthermore, more than 60%
of cells displayed γ-H2AX foci in the micronuclei (electronic
supplementary material, figure S2b). Heterogeneous DNA
damage response was observed in cells recovered from replica-
tion stress (electronic supplementary material, figure S2c).
Together, these results show TOP3B-deficient cells are more
sensitive to genotoxic stress and DNA damage.3. Discussion
Our data provide the first direct in vivo evidence that TOP3B
loss leads to increased R-loop formation. R-loops have gained
considerable attention over the last decade and despite there
being important benefits of R-loop formation in DNA replica-
tion, gene expression, class switch recombination and DNA
repair, studies have shown excessive R-loop formation can
lead to genome instability [11]. Available data suggest that
DSBs can be formed by a collision between R-loops and the
replication machinery [47,48]. Our hypothesis is that loss of
TOP3B causes increased the formation of R-loops, which
results in unresolved recombination intermediates that persist
into mitosis and lead to genome instability.
3.1. Loss of TOP3B causes genome instability
We found a corresponding increase in genome instability as a
result of TOP3B deficiency. This result was consistently ident-
ified in our independently targeted HCT116 TOP3B null
clones and patient TOP3B null lymphoblasts, strongly con-
firming our results. Micronuclei were mildly elevated across
all cell lines in non-stressed patient TOP3B null lymphoblast
cells. This argues for a slow accumulation of DNA damage
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10over time and suggests that pathological defects such as
cancer would be uncommon in less mature subjects. It is
useful to contrast this with patients with Bloom syndrome,
which similarly also show increased micronuclei and ultrafine
bridges [33]. Mutations in the BLM gene lead to patients often
being affected by cancers before they reach adulthood [49].
Why does TOP3B disruption not lead to early onset cancers
similar to BTRR subunits disruption? Disruption of BTRR
subunits and TOP3B causes a significant increase in UFBs
and to a lesser extent bulky DNA bridges. However, only dis-
ruption of BTRR subunits [34,50–52] causes a dramatic rise in
sister-chromatid exchange events, a process that carries an
inherent mutability. We would predict those with mutated
TOP3B would be likely to develop cancers much later in
life, consistent with our patient first diagnosed at 49 years
of age.3.2. TOP3B disruption markedly increases R-loop
formation and DNA damage
During development, cells are frequently exposed to a variety
of environmental stresses. Therefore, cells have evolved elab-
orate surveillance mechanisms that allow them to transientlyhalt their progression through the cell cycle, maintain the
arrest state and mount a response that should eventually
lead to efficient recovery and resumption of the division
cycle. Such mechanisms can coordinate the repair of DNA
damage, the activation of cell cycle checkpoints to facilitate
repair and apoptosis in order to eliminate cells with extensive
DNA damage [53]. Thymidine depletes cellular pools of
dCTP and causes replication fork stalling [54]; hydroxyurea
inhibits the incorporation of nucleotides by interfering with
enzyme ribonucleotide reductase and impedes replication
[55,56]; aphidicolin interferes with DNA replication by inhi-
biting DNA polymerases α, ɛ and δ [57]. These genotoxic
agents generate replication stress through different mechan-
isms, damaging DNA and result in the accumulation of
γ-H2AX foci in the cells [58].
Our data show that TOP3B-depleted cells are much more
likely to have DNA damage. This was seen in both null patient
lymphoblasts and HCT116 TOP3B null cells. DNA damage
increases the amount of problems observed in mitosis (e.g. a
large rise in ultrafine bridges; figure 3). Ultrafine bridges
most frequently arise due to unresolved replication intermedi-
ates, which are probably caused by excessive R-loop
formation [47,48]. Upon replication stress, TOP3B null cells
have a weaker checkpoint response than wide type cells,
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12suggesting a compromise in the cell cycle checkpoint control.
This is consistent with a previous observation in Top3b−/−
murine embryonic fibroblasts [59]. Previous studies have
indicated that the formation of micronuclei-staining positive
for γ-H2AX is associated with DNA replication stress and
irradiation-induced DSBs [32,60]. In this study, we observed
increased numbers of cells with micronuclei with discrete
γ-H2AX foci (electronic supplementary material, figure S1a),
further demonstrating the presence of intrinsic replication
stress in the TOP3B null cells.
Many proteins involved in DNA damage response and
repair have been implicated in the regulation of R-loop
accumulation. For example, RAD51 can promote R-loop-
mediated DNA damage at R-loops sites, rather than repair
DNA damage, leading to genome instability [61]. Patient
and engineered TOP3B null cells both had a significant
increase in R-loops (figure 4), and our recovery experiments
showed a greater increase in DNA damage in null cells
after genotoxic stress (figure 7). R-loops play a seemingly
contradictory role in the DNA repair pathway. R-loops may
promote DSB repair by facilitating homologous recombina-
tion and/or NHEJ [62,63]. However, R-loops can sequester
BRCA1 binding to DSBs, thereby preventing DNA repair
[64,65]. In this study, 53BP1 (NHEJ pathway) levels decreased
and RAD51 (homologous recombination pathway) levels sig-
nificantly increased in HCT116 TOP3B null cells, while levels
of BRCA1 foci formation remained unchanged. BRCA1 is a
main factor in homologous recombination repair in G2/S,
but evidence also indicate that it is involved in NHEJ in G1
[66]. Our results suggest the homologous recombination
pathway is activated in response to DSBs in HCT116
TOP3B null cells and preferred over NHEJ as expected in
G2/M. A further interesting result is the lower level of phos-
pho-P53 in TOP3B null cells relative to controls, particularly
in stressed cells (figure 6). In cells recovered from replication
stress, a heterogeneous DNA damage response was observed,
with phosphoP53 found to be dislocated from micronuclei
displaying γ-H2AX foci (electronic supplementary material,
figure S2c), suggesting that the DNA damage response in
micronuclei is defective [32]. Taken together, these data indi-
cate that TOP3B deletion might also compromise the DNA
repair signalling mechanism. The mechanism of TOP3B in
DNA repair is an important task for future investigations.3.3. TOP3B and neural defects
The case for TOP3B playing a role in neurogenesis is strong
with studies in fly and mice showing neural defects as a
result of TOP3B disruption [23] and human TOP3B disrupted
patients are predisposed to autism and schizophrenia [22].
TOP3B is enriched at multiple mRNAs with neural functions
related to autism and schizophrenia [23]. Our data show
increased baseline levels of γ-H2AX in unstressed cells
(figure 2b), but a reduced response in TOP3B null cells treated
with genotoxic agents (figure 6). This, at first glance, seems
paradoxical. Nevertheless, a search of the literature shows
this trend is strikingly mirrored in multiple studies with
cells exposed to DNA damage from schizophrenia patients
[67–70]. However, our TOP3B-deficient patient displays no
mental illness. This could be explained by the well-described
environmental and multigenic events needed for the onset of
these mental conditions.3.4. TOP3B and cancer
R-loop processing is gaining more attention in relation to cancer
[11]. Our own bioinformatic analyses show amarked increase in
homozygous deletions of TOP3B in a broad range of cancer
somatic tissues (tables 1 and 2). The link between TOP3B,
R-loops and cancer is telling. R-loop formation can increase
DSBs, which can, in turn, lead to chromosome translocations
or genome instability. Excessive R-loops can also alter gene
expression. Therefore, potential tumour suppressor or DNA
repair genes could be negatively affected in cells without
TOP3B. This is a very interesting new area and we believe over
time TOP3B will be added to the list of causative cancer genes.4. Material and methods
4.1. Subjects
Written consent was obtained from family members used in
this research study as part of the Austin Health Adult
Undiagnosed Diseases Program, according to Austin Health
policies. The ethic number is AU RED HREC Reference
Number: HREC/18/Austin/41.
4.2. Genomic microarray
Purified genomic DNA samples were processed by the Illu-
mina Infinium method and were hybridized onto Infinium
Omni2.5 v1.2 SNP-array chip (Illumina). Data were analysed
with KARYOSTUDIO v1.4 software (Illumina).
4.3. Cell lines
Lymphoblasts were obtained from wild-type TOP3B normal
(GM19238, Coriell), heterozygous TOP3B+/− parental (mother
and father) and a homozygous null TOP3B patient. The near
diploid human colorectal cell line HCT116 was engineered to
be homozygous null TOP3 using two separate guide RNAs,
thereby producing two independently targeted TOP3B
null lines (see below). All cell lines were maintained RPMI
medium supplemented with 10% fetal bovine serum and peni-
cillin–streptomycin, as described before [34]. All cells grew in
incubators with a humidified atmosphere containing 5% CO2
and 95% air at 37°C.
4.4. Replication stress
Cells were treated for 24 h with thymidine (2 mM),
hydroxyurea (2 mM) or aphidicolin (0.5 µg ml−1) to induce
replication stress. For recovery experiments, cells were
washed with PBS and incubated in the normal medium for
another 48 h after stress induction before being harvested
for immunofluorescent staining or grown for seven days for
the colony-forming assay.
4.5. Immunofluorescence microscopy and image
analysis
For immunofluorescence staining, HCT116 cells grown on
cover slides or lymphoblast cells pre-seeded on poly-L-
lysine-coated slides were fixed with 4% paraformaldehyde
(PFA) for 10 min, permeabilized with 0.3% triton-X100
royalsocietypublishing.org/journal/rsob
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with rabbit polyclonal anti-γ-H2A.X (phosopho S139) (1 :
800) (Abcam), mouse monoclonal anti-PICH (1 : 200)
(Millipore), mousemonoclonal anti-53BP1 (1 : 400) (Millipore),
mouse monoclonal anti-phospho-p53 (Ser15) (1 : 400) (CST)
or mouse monoclonal anti-Lamin A/C (1 : 200) (Chemicon).
Secondary antibodies were donkey anti-rabbit Alexa Fluor
488 (1 : 1000) (Invitrogen) or goat anti-mouse Alex Fluor 594
(1 : 1000) (Invitrogen). R-loop staining was performed as
described by Schwab et al. [71] with slight modifications.
Cells were pre-extracted with 0.5% triton-X100 before fixation
with 4% PFA. After permeabilization, cells were incubated
with 125 µg ml−1 RNase A at 37°C for 2 h. For negative con-
trols, cells were further incubated with 0.05 U µl−1 RNase H
(BioLabs) at 37°C for 4 h. Cells were then blocked with 5%
BSA in PBS at room temperature for 2 h before being stained
with mouse monoclonal anti-R-loop (S9.6) antibody (1 : 100)
(a gift from Dr Andrew Deans, St Vincent’s Institute,
Melbourne, Australia) at room temperature for 2 h. Cells
weremountedwithVectashieldmountingmediumcontaining
DAPI (Vetor Laboratories).
Images were acquired with a Delta Vision widefield decon-
volution microscope. Forty-eight section (0.2 µm per section)
imageswith 20× or 40× objective lens were taken and processed
by SOFTWORX 4.1. Cells were further analysed by IMARIS 8.1.2
for immunofluorescence intensity measurements. For intensity
measurement, three independent experiments were conducted
and at least 150 cells in each experiment were measured. Arbi-
trary intensity units ofAlex488 orAlex594 toDAPIwere plotted.
4.6. Immunoblotting
Immunoblotting was conducted as described [72]. In brief,
cells were resuspended in RIPA with fresh prepared EDTA-
free protease inhibitor (Roche) and incubated on ice for
15 min, followed by sonication. Forty micrograms protein
from each sample was subjected to 7.5% SDS–PAGE gels. Pri-
mary antibodies were rabbit monoclonal anti-TOP3B (1 : 500)
(Abcam) or mouse monoclonal anti-TOP3B (1 : 250) (Santa
Cruz Biotechnology) or mouse monoclonal anti-α-tubulin
(1 : 1000) (Sigma). Secondary antibodies were anti-rabbit
IgG-HRP (1 : 10 000) (Amersham) or anti-mouse IgG-HRP
(1 : 10 000) (Amersham). Western Blotting Luminol Reagent
(Santa Cruz Biotechnology) was used according to the
manufacturer’s instructions. Intensity was measured by Fiji
distribution of ImageJ.
4.7. Flow cytometry
FACS analysis was performed, as described in [72], and
analysed using FCS express 6.06.
4.8. Colony-forming assay
The colony-forming assay was conducted, as described by
Crowley et al. [73]. In brief, 300 cells/well were seeded in tri-
plicate on 6-well-plates for each sample. After treatment with
thymidine, hydroxyurea or aphidicolin for 24 h, cells were
washed and allowed to recover for 7 days. After 7 days, 6-
well-plates were placed on ice and wash 2× with ice-cold
PBS. Cells were fixed with ice-cold methanol for 10 min
and stained with a crystal violet staining solution for 5 min
at room temperature. The plates were carefully rinsed withddH2O and allowed to dry at room temperature overnight
before imaging. Colonies were counted by Fiji distribution
of IMAGEJ with colony_counter.jar plugin (https://imagej.
nih.gov/ij/plugins/colony-counter.html). Survival rate =
colony numbers/300.
4.9. Statistical analyses
Box plots and bar charts were generated using beeswarm
R package (https://cran.rproject.org/web/packages/bees
warm/index.html) or gplots (https://cran.r-project.org/
web/packages/gplots/index.html). Statistical analyses
were conducted using Student’s t-test (unpaired). P-values
less than 0.05 were considered as indicating statistically
significant differences. Error bars represent SEM.
4.10. CRISPR–Cas9 knockout
Two independent nicking CRISPR–Cas9 guide pairs were
designed using the CRISPR design tool at crispr.mit.edu.
Both pairs targeted the coding sequence of exon 6 of the
TOP3B gene (NM_001282112.2). The following target sites
for nicking pair no. 1, Guide A minus (5’–GAGAGCGCCT
CGTTGTGGTCAGG-3’), Guide B plus (5’-CAGGAGCTG
GACCTGCGAATCGG-3’), and no. 4 Guide A minus (5’-CC
ACTGAGAGCGCCTCGTTGTGG-3’), Guide B plus (5’–GAA
TCGGCTGTGCATTCACCAGG-3’). Annealed oligonucleo-
tides were cloned into the pSpCas9n (BB)-2A-GFP (PX461)
vector (Addgene plasmid ID: 48140) [74]. HCT116 cells were
transfected in 6-well trays with Lipofectamine 3000 (Thermo
Fisher Scientific) using the supplier’s protocol. Two days
after transfection, GFP-positive single cells were sorted by
FACS into 96-well trays. Genomic DNA from clones was
extracted using standardmethods followed by PCR amplifica-
tion screening across the CRISPR target site using the
following oligonucleotides; TB3-mf (5’-GTCACAGCTGGC
CACTCC-3’) TB3-mr (5’-GAGGGGGACCAGTAGAGG-3’).
PCR products were cloned into pGEM-T Easy (Promega)
and Sanger sequenced at the Australian Genome Research
Facility to confirm the presence of a knockout mutation.
Three clones with knockout alleles at the DNA and protein
levels were chosen for functional characterization.
4.11. Sister-chromatid exchange assay
Fresh blood cells were incubated for three to four days in RPMI
1640 medium/10% FBS with 20 µg ml−1 phytohaemagglutin.
BrdU (Sigma-Aldrich) was added to a final concentration
of 10 µg ml−1 for 30 h followed by 0.1 mg ml−1 colcemid
(ThermoFischer Scientific) treatment for 45 min before standard
metaphase chromosome harvest. Phosphate buffer pH 6.8 was
added to cover the dried slides to a depth of 2 mm. Slides
were then placed in a biosafety cabinet and were exposed to
UV light at a distance of 30 cm for 45 min. The slideswere briefly
rinsed in dH2O and added to prewarmed 2×SSC at 65°C
for 30 min, followed by another rinse in dH2O and stained in
Leishman’s stain (Sigma-Aldrich).
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